Annual Conference of Medicines for Europe
After one year break due to COVID 19, two weeks ago, we all gathered for the Annual Conference of Medicines for Europe, we share the main insights that our CEO Elisabeth Stampa explained in session 3 about how to make global manufacturing future-proof and more resilient and agile supply chains.
- The supply chain for pharmaceuticals is fragmented, complex and spread among different geographies
- 27% of API manufacturing facilities for the US are European, however, 1/3 of CEPs are for products manufactured in Europe and 2/3 from Asian manufacturers
- We are asking for clear guidelines, transparency and incentives
Full presentation: Future-Proof Global Manufacturing and Resilient Supply Chains